Learn More
Medchemexpress LLC C12-TLRa | 3067466-15-0 | C46H73N5O2 | 50 MG

Supplier: Medchemexpress LLC HY15387950MG
C12-TLRa is an ionized adjuvant lipid that targets TLR7/8 receptors in endosomes. It enhances mRNA delivery as a structural component of LNPs and boosts innate immune responses, making it suitable for research, including SARS-CoV-2 mRNA vaccines. Internally, C12-TLRa LNP (10-40 ng per well) shows dose-dependent mRNA transfection in DC2.4 cells with ~75% encapsulation efficiency. In vivo, C12-TLRa-substituted LNPs (5 μg mRNA per mouse) enhance mRNA transfection at injection sites and inguinal lymph nodes in C57BL/6 mice, significantly increasing mature DCs.
- Targets TLR7/8 receptors in endosomes
- Enhances mRNA delivery as a structural component of LNPs
- Boosts innate immune responses
- Suitable for SARS-CoV-2 mRNA vaccine research
- Dose-dependent mRNA transfection
- Enhances mRNA transfection at injection sites and inguinal lymph nodes
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.